AVANDIA Linked to Increased Risk of Heart Attacks and Death

Avandia, a widely prescribed diabetes drug has been linked to a significantly higher risk of heart attacks and death from cardiovascular causes according to a research analysis of 42 studies published in The New England Journal of Medicine on May 21, 2007. The study prompted the FDA to issue a Safety Alert the same day.

Avandia, generically known as rosiglitazone, and made by GlaxoSmithKline, was found to be associated with a 43% increased risk of heart attack and a 64% increased risk of death from cardiac related causes. The results are based upon an analysis of 15,560 patients who took Avandia and a control group of 12,283 patients who received placebos or other drugs. Avandia was approved in 1999 for treatment of type 2 diabetes, which affects approximately 18 to 20 million Americans.

If you or a loved one has suffered a heart attack or cardiac-related death after taking Avandia or Avandamet, then you may be entitled to monetary compensation for your injuries and damages. If you would like to have an attorney contact you for a free confidential consultation, please fill out the form below.

If you would prefer to speak to someone directly, please call us at 215-972-1376 in Pennsylvania or 856-665-3332 in New Jersey.

Disclaimer: Consult with your physician before discontinuing any prescription drug or making any changes in medical treatment. Do not rely on anything herein as medical advice.

Name: *required*

Telephone:

Email: *required*

Fax:

State:

Country:

Age:

Have you ever smoked cigarettes for a period
of time that exceeded 5 years?
Yes | No

Were you taking Avandia at the time of your cardiac event?
Yes | No

If no, when did not stop taking Avandia in relation
to your cardiac event?

Briefly describe your question or matter:

By typing OK into this box you are confirming that you wish to send your information to Meyerson & O'Neill.

The use of the Internet, and this form, to communicate with the firm will not establish an attorney-client relationship. Messages with confidential or very time-sensitive information should not be sent.

Pennsylvania Office
1700 Market Street
Suite 3025
Philadelphia
Pennsylvania 19103
Tele 215-972-1376
Fax 215-972-0277
Email us

New Jersey Office
83 East Lake Drive
P.O. Box 37
Audubon
New Jersey 08106
Tele 856-665-3332
Email us

Highlighted Areas:
Trasylol
Bayer AG is facing 78 lawsuits in the United States over its blood-clotting medication Trasylol.

AVANDIA
Linked to Increased Risk of Heart Attacks and Death.

Heparin Recall
The blood thinner has been implicated in at least four deaths and hundreds of life threatening adverse reactions.

Wrongful Death
If another’s negligence has resulted in a family member's death, contact us.

Legal Malpractice
One law firm that’s willing to pursue a lawyer whose malpractice has resulted in serious harm.

Dram Shop
Many states including Pennsylvania and New Jersey have enacted “dram shop” laws to prevent bars, taverns and restaurants from serving alcohol to visibly intoxicated persons.

Contact Lens Solution Recall
Complete® MoisturePlus™ multipurpose contact lens solution has been recalled after being linked to painful and potentially blinding eye infections.

Heart attack/stroke
If you believe that a doctor's misdiagnosis or improper treatment failed to prevent a heart attack or stroke, contact us.

Duragesic Pain Patch Recall
The patches which have expiration dates on or before December 2009 may have a cut along the drug reservoir which could leak and expose users to accidental overdoses of fentanyl.

Current Cases:
AVANDIA
Ortho Evra Litigation
Wrongful death
Legal Malpractice
Criminal defense

in Italiano
clicca qui